Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 1853-1860

  Sekuła, Małgorzata ^a   Miekus, Katarzyna ^b   Majka, Marcin ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Cervical carcinoma; CXCR4; Metastasis; Tumor growth

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; MATRIX METALLOPROTEINASE INHIBITOR; SHORT HAIRPIN RNA; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; CXCR4 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPLEEN METASTASIS; TUMOR INVASION; UTERINE CERVIX CARCINOMA; ANIMAL CELL; ANIMAL TISSUE; DOWN REGULATION; MALE; TUMOR GROWTH; ANIMAL; CARCINOMA; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; METASTASIS; PATHOLOGY; SCID MOUSE; SPLEEN; UTERINE CERVIX TUMOR;

ANIMALS; CARCINOMA; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG; MALE; MATRIX METALLOPROTEINASE 9; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; RECEPTORS, CXCR4; SPLEEN; UTERINE CERVICAL NEOPLASMS;

EID: 84899554551     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2383     Document Type: Article

References (39)

1. Zlotnik A and Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000.
2. Zlotnik A: Chemokines and cancer. Int J Cancer 119: 2026-2029, 2006.
3. Braunersreuther V, Mach F and Steffens S: The specific role of chemokines in atherosclerosis. Thromb Haemost 97: 714-721, 2007.
4. Ara T, Tokoyoda K, Sugiyama T, Kawabata K, et al: Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity 19: 257-267, 2003.
5. Taichman RS, Cooper C, Keller ET, et al: Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62: 1832-1837, 2002.
6. Kato M, Kitayama J, Kazama S and Nagawa H: Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5: 144-150, 2003.
7. Kucia M, Jankowski K, Reca R, et al: CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35: 233-245, 2004.
8. Helbig G, Christopherson KW, Bhat-Nakshatri P, et al: NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638, 2003.
9. Liang Z, Yoon Y, Votaw J, et al: Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65: 967-971, 2005.
10. Kucia M, Reca R, Miekus K, et al: Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23: 879-894, 2005.
11. Shiozawa Y, Nie B, Pienta KJ, et al: Cancer stem cells and their role in metastasis. Pharmacol Ther 138: 285-293, 2013.
12. Raman D, Baugher PJ, Thu YM and Richmond A: Role of chemokines in tumor growth. Cancer Lett 256: 137-165, 2007.
13. Teicher BA and Fricker SP: CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16: 2927-2931, 2010.
14. Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005.
15. Pecorino L: Molecular Biology of Cancer. Oxford University Press, 2012.
16. LaBarge MA: The difficulty of targeting cancer stem cell niches. Clin Cancer Res 16: 3121-3129, 2010.
17. Majka M, Drukala J, Lesko E, et al: SDF-1 alone and in co-operation with HGF regulates biology of human cervical carcinoma cells. Folia Histochem Cytobiol 44: 155-164, 2006.
18. Schiffman M, Wentzensen N, Wacholder S, et al: Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103: 368-383, 2011.
19. Kodama J, Hasengaowa, Kusumoto T, et al: Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann Oncol 18: 70-76, 2007.
20. González Martín A: Molecular biology of cervical cancer. Clin Transl Oncol 9: 347-354, 2007.
21. Sharp FA: RNA interference - 2001. Genes Dev 15: 485-490, 2001.
22. Felekkis K and Deltas C: RNA intereference: a powerful laboratory tool and its therapeutic implications. Hippokratia 10: 112-115, 2006.
23. Wu J, Chen C and Zhao KN: Phosphatidylinositol 3-kinase signaling as a therapeutic target for cervical cancer. Curr Cancer Drug Targets 13: 143-156, 2013.
24. Smith M, Luker KE, Garbow JR, et al: CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604-8612, 2004.
25. Kruse AJ, Baak JPA, de Bruin PC, et al: Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol 193: 48-54, 2001.
26. Fasching PA, Heusinger K, Haeberle L, et al: Ki-67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment. BMC Cancer 11: 486-499, 2011.
27. Martin B, Paesmans M, Mascaux C, et al: Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer 91: 2018-2025, 2004.
28. Locke M, Heywood M, Fawell S and Mackenzie IC: Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 65: 8944-8950, 2005.
29. Li H, Chen X, Calhoun-Davis T, et al: PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 68: 1820-1825, 2008.
30. Papini S, Grivel JC, Cecchetti D, et al: Isolation and clonal analysis of human epidermal keratinocyte stem cells in long-term culture. Stem Cells 21: 481-494, 2003.
31. Barrandon Y and Green H: Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84: 2302-2306, 1987.
32. Allinen M, Beroukhim R, Cai L, et al: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32, 2004.
33. Miekus K, Lukasiewicz E, Jarocha D, et al: The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation. Cell Death Dis 17: e459, 2013.
34. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
35. Davidson B, Goldberg I, Kopolovic J, et al: MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 73: 372-382, 1999.
36. Zhai Y, Hotary KB, Nan B, et al: Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res 65: 6543-6550, 2005.
37. Sheu BC, Lien HC, Ho HN, et al: Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res 63: 6537-6542, 2003.
38. Arsham AM, Plas DR, Thompson CB and Simon MC: Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis. Cancer Res 64: 3500-3507, 2004.
39. Lianga Z, Brooksa J, Willarda M, et al: CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun 359: 716-722, 2007.